Northwire Canada EditionSaturday, July 11, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Gencan Capital Inc. Announces Proposed Reverse Takeover by Ubercrete Advanced Materials Inc.

GCA · Price

Executive Summary

  • Gencan Capital Inc. entered into a Letter Agreement with Ubercrete Advanced Materials Inc. to effect a reverse takeover, whereby Ubercrete will become the holding company of the combined entity.
  • The transaction will involve consolidation of Gencan’s shares on a 2:1 basis, a one‑for‑one exchange of Ubercrete securities for shares of the resulting issuer, and replacement of all directors and officers with Ubercrete nominees.
  • Prior to or concurrent with closing, Ubercrete plans a private placement of up to C$5 million at C$0.25 per share to fund the combination.

Key Details

  • Letter Agreement Date: March 16, 2026.
  • Proposed Structure: Amalgamation, arrangement, share exchange or similar transaction resulting in Ubercrete becoming the holding company; resulting issuer shares to be listed on the Canadian Securities Exchange (CSE).
  • Share Consolidation: Gencan’s outstanding shares will be consolidated on a 2:1 basis.
  • Exchange Ratio: One‑for‑one exchange of Ubercrete securities for shares of the Resulting Issuer.
  • Corporate Changes: Post‑closing, all directors and officers of Gencan will be replaced by nominees of Ubercrete; company name to be changed at Ubercrete’s discretion; possible adoption of a new option plan.
  • Conditions to Closing:
  • Receipt of required third‑party consents and corporate/regulatory approvals.
  • Conditional CSE listing approval for the Resulting Issuer shares.
  • Satisfactory due diligence by both parties.
  • Execution of definitive agreement.
  • No material adverse change to either party.
  • Financing (Ubercrete): Private placement of common shares up to C$5,000,000 at C$0.25 per share; final terms (structure, fees) to be disclosed in subsequent releases.
  • Regulatory Disclosures: Transaction subject to tax, corporate and securities law advice; forward‑looking statements included with standard cautionary language.

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from Gencan Capital Inc.